Skip to content

Harald Nusser

Board Chair

Harald Nusser has an entrepreneurial approach to collaboration across industry sectors, which drives his ongoing success for achieving sustainable business development on a global scale. He currently leads the Global Health & Health Equity team at Merck KGaA, Darmstadt, Germany.

Previously, Harald was the Head of Global Patient Solutions at Gilead Sciences managing a global team overseeing 127 low- and middle-income countries. His focus is on pioneering sustainable business models to ensure that medicines for patients are affordable and accessible around the world.

Alongside his corporate career, Harald is also a Global Ambassador of the G20/G7 Health & Development Partnership.

Prior to joining Gilead, Harald was Head of Novartis Social Business where he introduced and ran several industry leading programs during his six-year tenure, earning himself an award from the Schwab Foundation in 2019, recognized as Corporate Social Intrapreneur of the Year. In 2018, Harald supported the Defeat-Non-Communicable Diseases Partnership as a board member during its inception year, tackling the significant global health challenges in low-resource countries.

Harald’s earlier career also includes several roles with increasing seniority during a 10-year tenure with Bayer Pharmaceuticals, and six years with Schering Pharmaceuticals in Harald’s hometown of Berlin. Harald holds a PhD in Mathematics from Free University of Berlin and an Executive MBA from University of Bradford. He also completed Executive Education ‘Leadership for System Change: Delivering Social Impact at Scale’ at Harvard University.